KARBE FRANK 4
4 · Better Therapeutics, Inc. · Filed Sep 15, 2022
Insider Transaction Report
Form 4
KARBE FRANK
DirectorSee Remarks
Transactions
- Purchase
Common Stock
2022-09-15$2.09/sh+50,000$104,695→ 50,000 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.06 to $2.10, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.